Revenue for Emcure Pharma Q2 rose by over 20%, totaling ₹2,002 Crore, driven by strong performance across segments.

In an exclusive interview with Nigeria Health Watch, Dr Mukhtar outlined the Executive Order's two-year validity, and its transformative provisions. Central to this includes the removal of tariffs, ...

Sanofi Korea Corporation (hereinafter referred to as Sanofi) successfully concluded the RSV story contest\ for parents who ...

The marketing applications with the EMA and FDA are for J&J and partner Genmab's Darzalex Faspro version of the anti-CD38 ...

Nigeria, the giant of Africa, has recently experienced a great downturn in its economy, leading to the exodus of several ...

Emcure Pharmaceuticals (BSE:544210, NSE: EMCURE) today announced its unaudited consolidated financial results for the qu ...

The expert panel further added, "The safety and efficacy data are to be deliberated in the presence of an independent expert ...